Insider Transactions in Q2 2021 at Karyopharm Therapeutics Inc. (KPTI)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+50.0%
|
-
|
|
Jun 02
2021
|
Stephen Mitchener SVP, Chief Business Officer |
SELL
Open market or private sale
|
Direct |
528
-17.6%
|
$4,752
$9.29 P/Share
|
|
Jun 01
2021
|
Michael Mason EVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
5,500
+8.76%
|
-
|
|
May 30
2021
|
Stephen Mitchener SVP, Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+33.33%
|
-
|
|
May 07
2021
|
Jatin Shah EVP, Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
23,250
+15.0%
|
$186,000
$8.6 P/Share
|
|
May 06
2021
|
Garen G Bohlin |
BUY
Open market or private purchase
|
Direct |
4,000
+50.0%
|
$28,000
$7.82 P/Share
|
|
May 03
2021
|
Richard A. Paulson President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
373,200
+50.0%
|
-
|